|
HSD17B4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.99840144432528E-15 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62481139653892E-12 |
| Normal-vs-Stage2 |
1.5596000046969E-08 |
| Normal-vs-Stage3 |
6.04819999999728E-05 |
| Normal-vs-Stage4 |
7.758600E-04 |
| Stage1-vs-Stage2 |
6.779000E-01 |
| Stage1-vs-Stage3 |
5.635400E-01 |
| Stage1-vs-Stage4 |
9.474200E-01 |
| Stage2-vs-Stage3 |
8.439200E-01 |
| Stage2-vs-Stage4 |
8.268400E-01 |
| Stage3-vs-Stage4 |
7.653200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62525548574877E-12 |
| Normal-vs-AfricanAmerican |
2.12385664610792E-13 |
| Normal-vs-Asian |
5.936800E-01 |
| Caucasian-vs-AfricanAmerican |
6.689400E-01 |
| Caucasian-vs-Asian |
4.228200E-01 |
| AfricanAmerican-vs-Asian |
3.948400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.55111512312578E-16 |
| Normal-vs-Female |
8.67306226837172E-13 |
| Male-vs-Female |
4.189600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.06089581564106E-11 |
| Normal-vs-Extreme_Weight |
1.11022302462516E-16 |
| Normal-vs-Obese |
1.65700786425305E-12 |
| Normal-vs-Extreme_Obese |
2.302900E-03 |
| Normal_Weight-vs-Extreme_Weight |
8.679600E-01 |
| Normal_Weight-vs-Obese |
8.512800E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.725600E-01 |
| Extreme_Weight-vs-Obese |
6.762200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.622800E-01 |
| Obese-vs-Extreme_Obese |
5.052800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.39050043385703E-10 |
| Normal-vs-Age(41-60Yrs) |
4.10782519111308E-15 |
| Normal-vs-Age(61-80Yrs) |
1.62569957495862E-12 |
| Normal-vs-Age(81-100Yrs) |
5.008700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.103200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.020600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.752000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.875800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.963600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.865200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62458935193399E-12 |
| Normal-VS-Type2 PRCC |
3.82710000024211E-07 |
| Normal-VS-KIRP CIMP |
1.29829480499666E-11 |
| Normal-VS-Unclassified PRCC |
7.03470004470574E-09 |
| Type1 PRCC-VS-Type2 PRCC |
7.595800E-04 |
| Type1 PRCC-VS-KIRP CIMP |
1.308840E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.241020E-03 |
| Type2 PRCC-VS-KIRP CIMP |
2.433400E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
6.300600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.258460E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.1247000542578E-09 |
| Normal-vs-N1 |
4.08260000250849E-08 |
| Normal-vs-N2 |
2.10290000000057E-05 |
| N0-vs-N1 |
8.762400E-01 |
| N0-vs-N2 |
3.951200E-01 |
| N1-vs-N2 |
3.730600E-01 |
|
|
